TickerFactsScreenerDevelopers

NEKTAR THERAPEUTICS (NKTR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$95.13M2010: -$28.25M2011: -$123.94M2012: -$141.20M2013: -$120.13M2014: -$16.48M2015: -$29.37M2016: -$112.86M2017: -$59.64M2018: $687.93M2019: -$440.04M2020: -$425.11M2021: -$446.10M2022: -$376.17M2023: -$263.68M2024: -$105.20M2025: -$140.10M-$140.10M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$140.10M-33.2%
2024-$105.20M+60.1%
2023-$263.68M+29.9%
2022-$376.17M+15.7%
2021-$446.10M-4.9%
2020-$425.11M+3.4%
2019-$440.04M-164.0%
2018$687.93M+1253.4%
2017-$59.64M+47.2%
2016-$112.86M-284.2%
2015-$29.37M-78.2%
2014-$16.48M+86.3%
2013-$120.13M+14.9%
2012-$141.20M-13.9%
2011-$123.94M-338.6%
2010-$28.25M+70.3%
2009-$95.13M—